Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05991960 · ClinicalTrials.gov registry record
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL
A clinical trial, sponsored by Johnson & Johnson Surgical Vision.
- Completed
- Registry status
- 96
- Enrollment target
NCT05991960: Completed study, sponsored by Johnson & Johnson Surgical Vision.
NCT05991960 is a clinical trial that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05991960 has completed, sponsored by Johnson & Johnson Surgical Vision.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
Primary Outcome
Visual Acuity will be collected via observed case data in units of logMAR.
Interventions
- DEVICE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2023-12-04 |
What the finished NCT05991960 record still lists
NCT05991960 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.
NCT05991960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05991960 about?
NCT05991960 is a clinical study titled "Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL". Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.
What is the current status of trial NCT05991960?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2023-09-11. Estimated completion is 2023-12-04.
What interventions are being tested in trial NCT05991960?
The interventions under investigation include: Intervention (DEVICE).
Who is sponsoring clinical trial NCT05991960?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI